葛兰素史克总公司向中国人民的致歉声明“333体育手机版入口”

发布时间：2024-11-29 丨 浏览次数：

本文摘要：FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities，GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains，andhasbeenfoundguiltyofbribingnon-governmentpersonnel.GSKplcfullyacceptsthefactsandevidenceoftheinvestigation，andtheverdictoftheChinesejudicialauthorities.Furthermore，GSKplcsincerelyapologisestotheChinesepatients，doctorsandhospitals，andtotheChineseGovernmentandtheChinesepeople.GSKplcdeeplyregretsthedamagecaused.GSKplcalsoapologisesfortheharmcausedtoindividualswhowereillegallyinvestigatedbyGSKCI.TheillegalactivitiesofGSKCIareaclearbreachofGSKplc’sgovernanceandcomplianceprocedures;andarewhollycontrarytothevaluesandstandardsweexpectfromouremployees.Itisdeeplydisappointingthattheseissueswerenotidentifiedandaddressed.GSKplchasreflecteddeeplyandlearnedfromitsmistakes，hastakenstepstocomprehensivelyrectifytheissuesidentifiedattheoperationsofGSKCI，andmustworkhardtoregainthetrustoftheChinesepeople.Today，GSKplcmakesafurthercommitmenttotheChinesegovernmentandpeoplethatGSKCIwilltaketangibleactionstoestablishitselfasamodelforreforminChina’shealthcareindustry：bycontinuingtoinvestinChinaandsupportingChinasscientificdevelopment;andbyfurtherdevelopmentofinnovativenewmedicinesandvaccinesfordiseasesprevalentinChina.GSKCIwillalsoincreaseaccesstoitsproductsinbothcityandruralareasofChinathroughgreaterexpansionofproductionandthroughpriceflexibility.
FollowingacomprehensiveinvestigationbytheChinesejudicialauthorities，GSKChinaInvestmentCo.Ltd(GSKCI)hasbeenidentifiedaccordingtoChineselawtohaveofferedmoneyorpropertytonon-governmentpersonnelinordertoobtainimpropercommercialgains，andhasbeenfoundguiltyofbribingnon-governmentpersonnel.GSKplcfullyacceptsthefactsandevidenceoftheinvestigation，andtheverdictoftheChinesejudicialauthorities.Furthermore，GSKplcsincerelyapologisestotheChinesepatients，doctorsandhospitals，andtotheChineseGovernmentandtheChinesepeople.GSKplcdeeplyregretsthedamagecaused.GSKplcalsoapologisesfortheharmcausedtoindividualswhowereillegallyinvestigatedbyGSKCI.TheillegalactivitiesofGSKCIareaclearbreachofGSKplc’sgovernanceandcomplianceprocedures;andarewhollycontrarytothevaluesandstandardsweexpectfromouremployees.Itisdeeplydisappointingthattheseissueswerenotidentifiedandaddressed.GSKplchasreflecteddeeplyandlearnedfromitsmistakes，hastakenstepstocomprehensivelyrectifytheissuesidentifiedattheoperationsofGSKCI，andmustworkhardtoregainthetrustoftheChinesepeople.Today，GSKplcmakesafurthercommitmenttotheChinesegovernmentandpeoplethatGSKCIwilltaketangibleactionstoestablishitselfasamodelforreforminChina’shealthcareindustry：bycontinuingtoinvestinChinaandsupportingChinasscientificdevelopment;andbyfurtherdevelopmentofinnovativenewmedicinesandvaccinesfordiseasesprevalentinChina.GSKCIwillalsoincreaseaccesstoitsproductsinbothcityandruralareasofChinathroughgreaterexpansionofproductionandthroughpriceflexibility.
本文关键词：333体育平台app,333体育官网登录入口,333体育app下载安装,333体育手机版入口

本文来源：333体育平台app-www.msalphabet.com